pharmaceuticals

Gland Pharma Limited (GLAND) Q4 FY23 Earnings Concall Transcript

● May 22, 2023

Gland Pharma Limited (NSE:GLAND) Q4 FY23 Earnings Concall dated May. 18, 2023. Corporate Participants: Sumanta Bajpayee — Vice President, Finance and Investor...

Earnings | Abbott India Ltd (NSE: ABBOTTINDIA): Q4FY23 Results Out; Total Income rises 9% YoY.

● May 19, 2023

Abbott India Ltd is a prominent multinational pharmaceutical company operating in India. Established in 1944, it has emerged as a...

Earnings Summary Of Glenmark Pharmaceuticals Limited For Q4 FY23

● May 19, 2023

Glenmark Pharmaceuticals Limited is a global pharmaceutical company headquartered in Mumbai, India. Established in 1977, the company has grown to...

Earnings | BDH Industries Ltd. (NSE: BDH): Q4FY23 Results Out; Total Income rises 77% YoY.

● May 18, 2023

BDH Industries Ltd. is a manufacturing company that specializes in the production of therapeutic formulations, encompassing a wide range of...

Zydus Lifescience Ltd Q4FY23 results out, revenue grows by 32%

● May 18, 2023

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From...

Earnings Summary Of Gland Pharma Limited For Q4 FY23

● May 18, 2023

Gland Pharma Limited specializes in the production of sterile injectable formulations, including vials, ampoules, pre-filled syringes, and lyophilized products. The...

Earnings Summary Of Glaxosmithkline Pharmaceuticals Limited For Q4 FY23

● May 17, 2023

GlaxoSmithKline Pharmaceuticals Limited is a renowned Indian pharmaceutical company that operates in the research, development, manufacturing, and marketing of a...

Granules India Ltd (GRANULES) Q4 FY23 Earnings Concall Transcript

● May 17, 2023

Granules India Ltd (NSE:GRANULES) Q4 FY23 Earnings Concall dated May. 16, 2023. Corporate Participants: Irfan Raeen — Investor Relations Krishna Prasad — Chairman and...

Granules India Limited Q4 FY23; Net Profit Increased By 8%

● May 16, 2023

Granules India Limited reported Total Income for Q4 FY23 of ₹1,198.87 Crore up from ₹1,033.93 Crore year on year, a...

Earnings Summary Of Granules India Limited For Q4 FY23

● May 16, 2023

Granules India Limited is a pharmaceutical manufacturing company based in India. The company is engaged in the production and sale...